Thrombotic Microangiopathy Associated with Systemic Adeno-Associated Virus Gene Transfer: Review of Reported Cases
Human Gene Therapy · 2025-02 · 36 (3-4) · 64-76
DOI: 10.1089/hum.2024.156 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Gene Therapy, online erschienen am 10.02.2025. Verfasst von Genevieve A Laforet. Beteiligte Einrichtung: BridgeBio Gene Therapy, Palo Alto, California, USA. Hauptthemen laut MEDLINE: Dependovirus, Thrombotic Microangiopathies, Genetic Therapy, Genetic Vectors. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Complement-mediated thrombotic microangiopathy (TMA) in the form of atypical hemolytic uremic syndrome (aHUS) has emerged as an immune complication of systemic adeno-associated virus (AAV) gene transfer that was unforeseen based on nonclinical studies. Understanding this phenomenon in the clinical setting has been limited by incomplete data and a lack of uniform diagnostic and reporting criteria. While apparently rare based on available information, AAV-associated TMA/aHUS can pose a substantial risk to patients including one published fatality. Reported cases were originally limited to pediatric Duchenne muscular dystrophy patients receiving micro- or mini-dystrophin transgenes via AAV9 but have subsequently been reported in both pediatric and adult patients across a range of disorders, transgenes, promoters, and AAV capsid types. This article provides an introduction to the complement system, TMA and aHUS, and anticomplement therapies, then presents clinical reviews of AAV-associated TMA/aHUS cases that have been reported publicly. Finally, exploration of risk factors and current and future mitigation approaches are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BridgeBio Gene Therapy, Palo Alto, California, USA.
ORCID-Profile: Genevieve A Laforet
Zitieren
APA
Laforet, G. A. (2025). Thrombotic Microangiopathy Associated with Systemic Adeno-Associated Virus Gene Transfer: Review of Reported Cases. Human Gene Therapy, 36(3-4), 64-76. https://doi.org/10.1089/hum.2024.156
Vancouver
Laforet GA. Thrombotic Microangiopathy Associated with Systemic Adeno-Associated Virus Gene Transfer: Review of Reported Cases. Human Gene Therapy. 2025;36(3-4):64-76. doi:10.1089/hum.2024.156
BibTeX
@article{Laforet2025,
author = {Laforet, Genevieve A},
title = {Thrombotic Microangiopathy Associated with Systemic Adeno-Associated Virus Gene Transfer: Review of Reported Cases},
journal = {Human Gene Therapy},
year = {2025},
volume = {36},
number = {3-4},
pages = {64--76},
doi = {10.1089/hum.2024.156}
}
EUVIMED